StemBook is an open access collection of content covering a range of topics related to stem cell biology written by top researchers in the field. StemBook is aimed at stem cell and non-specialist researchers and, together with StemJournal, is one of the components in our forthcoming portal StemHub (details soon).
StemBook publishes both invited and spontaneously-submitted reviews, which have been submitted to StemJournal. These review articles are republished as chapters in StemBook. All submitted reviews undergo the normal peer-review process. Submissions are welcomed via StemJournal (more details coming soon).
StemBook also publishes validated protocols, in collaboration with Stem Cell COREdinates, encompassing various methods to generate, edit and differentiate induced pluripotent stem cells into various lineages. New protocols, submitted for peer review and accepted for publication in StemJournal, will be archived in StemBook under the appropriate topic in the Protocols section.
News, commentaries and meeting announcements of interest to stem cell researchers will also be published in StemBook. Additional content includes:
- Journal Stream – weekly curated selections of the very latest stem cell literature;
- Forums – discussions with and profiles of researchers and laboratories;
- Resources – laboratory resources, funding sources, etc.
In 2017, IOS Press acquired StemBook (see here). Originally, in addition to the contributions of the Editorial Board and the stem cell research community, the project was developed in collaboration with several other enterprises, including Harvard Stem Cell Institute and Harvard’s Initiative in Innovative Computing. The Initiative in Innovative Computing created the Scientific Collaboration Framework (SCF), the extensible software infrastructure used for the project. SCF and the StemBook project were funded, in part, by a generous grant from an anonymous foundation and also appreciates the input of WormBase's Textpresso team. IOS Press will continue to develop and expand StemBook to include new content and new functionalities.
Doug Melton, Harvard Stem Cell Institute, USA
Chad A. Cowan, Harvard Stem Cell Institute, USA
Bradley E. Bernstein, Dana-Farber Cancer Institute, USA
Sangeeta Bhatia, Harvard Stem Cell Institute, USA
Ali Brivanlou, The Rockefeller University, USA
George Daley, Harvard Stem Cell Institute, USA
Patricia K. Donahoe, Harvard Stem Cell Institute, USA
Kevin Eggan, Harvard Stem Cell Institute, USA
Fred Gage, Salk Institute, USA
Rudolf Jaenisch, Whitehead Institute, USA
Peter Laird, Van Andel Research Institute, USA
Haifan Lin, Yale University, USA
Diane Mathis, Harvard Stem Cell Institute, USA
Brock Reeve, Harvard Stem Cell Institute, USA
Jerome Ritz, Dana-Farber Cancer Institute, USA
David Scadden, Harvard Stem Cell Institute, USA
Alexander F. Schier, University of Basel's Biozentrum, Switzerland
Les Silberstein, Harvard Stem Cell Institute, USA
Shinya Yamanaka, Gladstone Institutes, USA, and Center for iPS Cell Research and Application, Japan